Oruka Therapeutics, Inc. (ORKA) stock
ORKANasdaqPharmaceutical PreparationsFiscal year ends December 31
$96.32−2.92 (-2.94%)
Close on Nov 17, 2026Market cap $6.38BP/E –Yield –
Oruka Therapeutics cash
Cash and short-term investments held at the end of each period.
Oruka Therapeutics's cash was $873.56M at Jun 30, 2026. For fiscal 2025 it was $337.04M, down 10.3% from the year before. Over ten years it grew 24.1% a year on average. The highest annual figure on record is $375.65M in fiscal 2024.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $337.04M | -10.3% |
| FY2024 | Dec 31, 2024 | $375.65M | +903.6% |
| FY2023 | Dec 31, 2023 | $37.43M | -11.8% |
| FY2022 | Dec 31, 2022 | $42.45M | -20.5% |
| FY2021 | Dec 31, 2021 | $53.36M | +8.7% |
| FY2020 | Dec 31, 2020 | $49.07M | +486.8% |
| FY2019 | Dec 31, 2019 | $8.36M | +26.6% |
| FY2018 | Dec 31, 2018 | $6.61M | -43.8% |
| FY2017 | Dec 31, 2017 | $11.75M | -44.5% |
| FY2016 | Dec 31, 2016 | $21.16M | -45.5% |
| FY2015 | Dec 31, 2015 | $38.80M | +152.7% |
| FY2014 | Dec 31, 2014 | $15.35M | -8.4% |
| FY2013 | Dec 31, 2013 | $16.76M | +473.8% |
| FY2012 | Dec 31, 2012 | $2.92M | -50.9% |
| FY2011 | Dec 31, 2011 | $5.94M | -15.4% |
| FY2010 | Dec 31, 2010 | $7.03M | -9.5% |
| FY2009 | Dec 31, 2009 | $7.76M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $873.56M | +166.0% |
| Q1 FY2026 | Mar 31, 2026 | $388.83M | +11.4% |
| Q4 FY2025 | Dec 31, 2025 | $337.04M | -10.3% |
| Q3 FY2025 | Sep 30, 2025 | $349.16M | -15.0% |
| Q2 FY2025 | Jun 30, 2025 | $328.41M | +2071.9% |
| Q1 FY2025 | Mar 31, 2025 | $349.09M | +1158.3% |
| Q4 FY2024 | Dec 31, 2024 | $375.65M | +903.6% |
| Q3 FY2024 | Sep 30, 2024 | $410.88M | +967.6% |
| Q2 FY2024 | Jun 30, 2024 | $15.12M | -62.3% |
| Q1 FY2024 | Mar 31, 2024 | $27.74M | -32.1% |
| Q4 FY2023 | Dec 31, 2023 | $37.43M | -11.8% |
| Q3 FY2023 | Sep 30, 2023 | $38.49M | -12.4% |
| Q2 FY2023 | Jun 30, 2023 | $40.16M | -13.5% |
| Q1 FY2023 | Mar 31, 2023 | $40.85M | -16.7% |
| Q4 FY2022 | Dec 31, 2022 | $42.45M | -20.5% |
| Q3 FY2022 | Sep 30, 2022 | $43.94M | -24.6% |
| Q2 FY2022 | Jun 30, 2022 | $46.44M | -26.5% |
| Q1 FY2022 | Mar 31, 2022 | $49.06M | -26.7% |
| Q4 FY2021 | Dec 31, 2021 | $53.36M | +8.7% |
| Q3 FY2021 | Sep 30, 2021 | $58.31M | +14.1% |
| Q2 FY2021 | Jun 30, 2021 | $63.20M | +846.9% |
| Q1 FY2021 | Mar 31, 2021 | $66.93M | +700.3% |
| Q4 FY2020 | Dec 31, 2020 | $49.07M | +408.8% |
| Q3 FY2020 | Sep 30, 2020 | $51.10M | +412.7% |
| Q1 FY2020 | Mar 31, 2020 | $6.67M | -16.6% |
| Q4 FY2019 | Dec 31, 2019 | $8.36M | +26.6% |
| Q3 FY2019 | Sep 30, 2019 | $9.65M | +19.7% |
| Q2 FY2019 | Jun 30, 2019 | $9.97M | +3.4% |
| Q1 FY2019 | Mar 31, 2019 | $8.01M | -33.8% |
| Q4 FY2018 | Dec 31, 2018 | $6.61M | -43.8% |
| Q3 FY2018 | Sep 30, 2018 | $8.06M | -49.5% |
| Q2 FY2018 | Jun 30, 2018 | $9.64M | -39.8% |
| Q1 FY2018 | Mar 31, 2018 | $12.10M | -37.0% |
| Q4 FY2017 | Dec 31, 2017 | $11.75M | -44.5% |
| Q3 FY2017 | Sep 30, 2017 | $15.95M | -32.0% |
| Q2 FY2017 | Jun 30, 2017 | $16.01M | -39.3% |
| Q1 FY2017 | Mar 31, 2017 | $19.21M | – |
| Q4 FY2016 | Dec 31, 2016 | $21.16M | – |
| Q3 FY2016 | Sep 30, 2016 | $23.47M | – |
| Q2 FY2016 | Jun 30, 2016 | $26.36M | – |
See a number that looks wrong?